Shock and unresponsiveness to repeated courses of intravenous immunoglobulin in Kawasaki disease: a nationwide database study

Background We aimed to investigate the clinical implications of unresponsiveness to single or repeated courses intravenous immunoglobulin (IVIG) and Kawasaki disease (KD) shock syndrome in patients with KD in an era of a single brand of IVIG. Methods Data were collected from National Health Insuranc...

Full description

Saved in:
Bibliographic Details
Published inPediatric research Vol. 87; no. 5; pp. 961 - 966
Main Authors Liang, Yun-Chieh, Chang, Chin-Hao, Lin, Ming-Tai, Kao, Feng-Yu, Huang, San-Kuei, Wu, Mei-Hwan
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.04.2020
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN0031-3998
1530-0447
1530-0447
DOI10.1038/s41390-019-0668-1

Cover

Loading…
Abstract Background We aimed to investigate the clinical implications of unresponsiveness to single or repeated courses intravenous immunoglobulin (IVIG) and Kawasaki disease (KD) shock syndrome in patients with KD in an era of a single brand of IVIG. Methods Data were collected from National Health Insurance database 2010–2013. Characteristics of the KD patients were analyzed, including age, gender, shock, and associated coronary aneurysms. Results There were 3043 KD patients (male: 1872) identified. Among them, 46 (1.51%) had KDSS, 261 patients (8.5%) had IVIG unresponsiveness, and 225 patients (7.4%) developed coronary aneurysms. Moreover, 51 patients did not respond to the second course IVIG therapy, i.e., re-IVIG unresponsiveness. KDSS was associated with the occurrence of IVIG unresponsiveness ( P  < 10 −4 ) and re-IVIG unresponsiveness ( P  = 0.02). In addition to male gender and KD shock syndrome, IVIG unresponsiveness (OR: 2.18, 95% CI: 1.48–3.22, P  = 0.001) and re-IVIG unresponsiveness (OR: 2.87, 95% CI: 1.40–5.89, P  = 0.004) were both independent risk factors for coronary aneurysms. Conclusions In a nationwide KD cohort, both IVIG unresponsiveness and re-IVIG unresponsiveness increase the risk of coronary aneurysms. Such observation addresses the importance of refining the treatment for IVIG unresponsiveness, at least in those with KD shock syndrome.
AbstractList Background We aimed to investigate the clinical implications of unresponsiveness to single or repeated courses intravenous immunoglobulin (IVIG) and Kawasaki disease (KD) shock syndrome in patients with KD in an era of a single brand of IVIG. Methods Data were collected from National Health Insurance database 2010–2013. Characteristics of the KD patients were analyzed, including age, gender, shock, and associated coronary aneurysms. Results There were 3043 KD patients (male: 1872) identified. Among them, 46 (1.51%) had KDSS, 261 patients (8.5%) had IVIG unresponsiveness, and 225 patients (7.4%) developed coronary aneurysms. Moreover, 51 patients did not respond to the second course IVIG therapy, i.e., re-IVIG unresponsiveness. KDSS was associated with the occurrence of IVIG unresponsiveness ( P  < 10 −4 ) and re-IVIG unresponsiveness ( P  = 0.02). In addition to male gender and KD shock syndrome, IVIG unresponsiveness (OR: 2.18, 95% CI: 1.48–3.22, P  = 0.001) and re-IVIG unresponsiveness (OR: 2.87, 95% CI: 1.40–5.89, P  = 0.004) were both independent risk factors for coronary aneurysms. Conclusions In a nationwide KD cohort, both IVIG unresponsiveness and re-IVIG unresponsiveness increase the risk of coronary aneurysms. Such observation addresses the importance of refining the treatment for IVIG unresponsiveness, at least in those with KD shock syndrome.
BackgroundWe aimed to investigate the clinical implications of unresponsiveness to single or repeated courses intravenous immunoglobulin (IVIG) and Kawasaki disease (KD) shock syndrome in patients with KD in an era of a single brand of IVIG.MethodsData were collected from National Health Insurance database 2010–2013. Characteristics of the KD patients were analyzed, including age, gender, shock, and associated coronary aneurysms.ResultsThere were 3043 KD patients (male: 1872) identified. Among them, 46 (1.51%) had KDSS, 261 patients (8.5%) had IVIG unresponsiveness, and 225 patients (7.4%) developed coronary aneurysms. Moreover, 51 patients did not respond to the second course IVIG therapy, i.e., re-IVIG unresponsiveness. KDSS was associated with the occurrence of IVIG unresponsiveness (P < 10−4) and re-IVIG unresponsiveness (P = 0.02). In addition to male gender and KD shock syndrome, IVIG unresponsiveness (OR: 2.18, 95% CI: 1.48–3.22, P = 0.001) and re-IVIG unresponsiveness (OR: 2.87, 95% CI: 1.40–5.89, P = 0.004) were both independent risk factors for coronary aneurysms.ConclusionsIn a nationwide KD cohort, both IVIG unresponsiveness and re-IVIG unresponsiveness increase the risk of coronary aneurysms. Such observation addresses the importance of refining the treatment for IVIG unresponsiveness, at least in those with KD shock syndrome.
We aimed to investigate the clinical implications of unresponsiveness to single or repeated courses intravenous immunoglobulin (IVIG) and Kawasaki disease (KD) shock syndrome in patients with KD in an era of a single brand of IVIG. Data were collected from National Health Insurance database 2010-2013. Characteristics of the KD patients were analyzed, including age, gender, shock, and associated coronary aneurysms. There were 3043 KD patients (male: 1872) identified. Among them, 46 (1.51%) had KDSS, 261 patients (8.5%) had IVIG unresponsiveness, and 225 patients (7.4%) developed coronary aneurysms. Moreover, 51 patients did not respond to the second course IVIG therapy, i.e., re-IVIG unresponsiveness. KDSS was associated with the occurrence of IVIG unresponsiveness (P < 10 ) and re-IVIG unresponsiveness (P = 0.02). In addition to male gender and KD shock syndrome, IVIG unresponsiveness (OR: 2.18, 95% CI: 1.48-3.22, P = 0.001) and re-IVIG unresponsiveness (OR: 2.87, 95% CI: 1.40-5.89, P = 0.004) were both independent risk factors for coronary aneurysms. In a nationwide KD cohort, both IVIG unresponsiveness and re-IVIG unresponsiveness increase the risk of coronary aneurysms. Such observation addresses the importance of refining the treatment for IVIG unresponsiveness, at least in those with KD shock syndrome.
We aimed to investigate the clinical implications of unresponsiveness to single or repeated courses intravenous immunoglobulin (IVIG) and Kawasaki disease (KD) shock syndrome in patients with KD in an era of a single brand of IVIG.BACKGROUNDWe aimed to investigate the clinical implications of unresponsiveness to single or repeated courses intravenous immunoglobulin (IVIG) and Kawasaki disease (KD) shock syndrome in patients with KD in an era of a single brand of IVIG.Data were collected from National Health Insurance database 2010-2013. Characteristics of the KD patients were analyzed, including age, gender, shock, and associated coronary aneurysms.METHODSData were collected from National Health Insurance database 2010-2013. Characteristics of the KD patients were analyzed, including age, gender, shock, and associated coronary aneurysms.There were 3043 KD patients (male: 1872) identified. Among them, 46 (1.51%) had KDSS, 261 patients (8.5%) had IVIG unresponsiveness, and 225 patients (7.4%) developed coronary aneurysms. Moreover, 51 patients did not respond to the second course IVIG therapy, i.e., re-IVIG unresponsiveness. KDSS was associated with the occurrence of IVIG unresponsiveness (P < 10-4) and re-IVIG unresponsiveness (P = 0.02). In addition to male gender and KD shock syndrome, IVIG unresponsiveness (OR: 2.18, 95% CI: 1.48-3.22, P = 0.001) and re-IVIG unresponsiveness (OR: 2.87, 95% CI: 1.40-5.89, P = 0.004) were both independent risk factors for coronary aneurysms.RESULTSThere were 3043 KD patients (male: 1872) identified. Among them, 46 (1.51%) had KDSS, 261 patients (8.5%) had IVIG unresponsiveness, and 225 patients (7.4%) developed coronary aneurysms. Moreover, 51 patients did not respond to the second course IVIG therapy, i.e., re-IVIG unresponsiveness. KDSS was associated with the occurrence of IVIG unresponsiveness (P < 10-4) and re-IVIG unresponsiveness (P = 0.02). In addition to male gender and KD shock syndrome, IVIG unresponsiveness (OR: 2.18, 95% CI: 1.48-3.22, P = 0.001) and re-IVIG unresponsiveness (OR: 2.87, 95% CI: 1.40-5.89, P = 0.004) were both independent risk factors for coronary aneurysms.In a nationwide KD cohort, both IVIG unresponsiveness and re-IVIG unresponsiveness increase the risk of coronary aneurysms. Such observation addresses the importance of refining the treatment for IVIG unresponsiveness, at least in those with KD shock syndrome.CONCLUSIONSIn a nationwide KD cohort, both IVIG unresponsiveness and re-IVIG unresponsiveness increase the risk of coronary aneurysms. Such observation addresses the importance of refining the treatment for IVIG unresponsiveness, at least in those with KD shock syndrome.
Author Wu, Mei-Hwan
Lin, Ming-Tai
Huang, San-Kuei
Kao, Feng-Yu
Chang, Chin-Hao
Liang, Yun-Chieh
Author_xml – sequence: 1
  givenname: Yun-Chieh
  surname: Liang
  fullname: Liang, Yun-Chieh
  organization: Clinical Trial Center, National Taiwan University Hospital
– sequence: 2
  givenname: Chin-Hao
  surname: Chang
  fullname: Chang, Chin-Hao
  organization: Department of Medical Research, National Taiwan University Hospital
– sequence: 3
  givenname: Ming-Tai
  orcidid: 0000-0002-1718-7137
  surname: Lin
  fullname: Lin, Ming-Tai
  email: mingtailin@ntu.edu.tw
  organization: Department of Pediatrics, National Taiwan University Hospital and Medical College, National Taiwan University
– sequence: 4
  givenname: Feng-Yu
  surname: Kao
  fullname: Kao, Feng-Yu
  organization: Taiwan Bureau of National Health Insurance
– sequence: 5
  givenname: San-Kuei
  surname: Huang
  fullname: Huang, San-Kuei
  organization: Institute of Hospital and Health Care Administration, National Yang-Ming University
– sequence: 6
  givenname: Mei-Hwan
  surname: Wu
  fullname: Wu, Mei-Hwan
  organization: Department of Pediatrics, National Taiwan University Hospital and Medical College, National Taiwan University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31711068$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1u1TAQhS1URG8LD8AGWWLTTcATO3HMDlW0ICp1UVhHjj0pbhP74kmouuDd63ILSJVgZWn8nfk554DtxRSRsZcg3oCQ3VtSII2oBJhKtG1XwRO2gUaWilJ6j22EkFBJY7p9dkB0JQSoplPP2L4EDSDabsN-XnxL7prb6PkaM9I2RQo_MCIRXxLPuEW7oOcurZmQeBp5iEu2BUkr8TDPa0yXUxrWKcTyxT_bG0v2OnAfCC3hO255tEtI8SZ45N4udihlTsvqb5-zp6OdCF88vIfs68mHL8cfq7Pz00_H788qJ3W9VN54KQasoRONVo3yGjxaAOMHp9CibqQzrqlh1GZA5z0KsKMYrEFhvGnkITva9d3m9H1FWvo5kMNpshHLGX0tQQmQqpYFff0IvSqnx7JdoTpdq1a2ulCvHqh1mNH32xxmm2_738YWAHaAy4ko4_gHAdHfh9fvwutLeP19eD0UjX6kcWH5ZV0xPEz_VdY7JZUp8RLz36X_LboDYTOv8Q
CitedBy_id crossref_primary_10_1016_j_coph_2020_08_008
crossref_primary_10_1097_INF_0000000000002982
crossref_primary_10_1016_j_cjca_2021_05_014
crossref_primary_10_3389_fcvm_2024_1405012
crossref_primary_10_1016_j_jfma_2020_12_010
crossref_primary_10_3389_fped_2024_1450710
crossref_primary_10_1007_s10067_020_05534_1
crossref_primary_10_12677_ACM_2023_1351058
crossref_primary_10_5812_ijp_120214
crossref_primary_10_3390_children9121819
crossref_primary_10_1016_j_cjca_2024_11_027
crossref_primary_10_1155_2021_1486089
Cites_doi 10.1016/j.jpeds.2016.09.052
10.1016/S0140-6736(11)61930-2
10.1016/S1875-9572(10)60014-9
10.1016/j.jpeds.2007.12.021
10.1161/CIR.0000000000000484
10.1253/circj.CJ-66-0096
10.1016/j.jacc.2015.12.073
10.3345/kjp.2016.59.10.408
10.1093/eurheartj/ehm193
10.1046/j.1442-200x.2001.01373.x
10.1542/peds.2011-0148
10.1542/peds.2008-1275
10.1542/peds.2008-1871
10.1161/01.CIR.0000145143.19711.78
10.1136/archdischild-2014-306427
10.1097/INF.0b013e31829efae6
10.1111/1756-185X.13208
10.1007/978-4-431-56039-5
ContentType Journal Article
Copyright International Pediatric Research Foundation, Inc 2019
International Pediatric Research Foundation, Inc 2019.
Copyright_xml – notice: International Pediatric Research Foundation, Inc 2019
– notice: International Pediatric Research Foundation, Inc 2019.
DBID AAYXX
CITATION
NPM
3V.
7X7
7XB
88E
8C1
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
DOI 10.1038/s41390-019-0668-1
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
ProQuest Public Health
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
ProQuest Public Health
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1530-0447
EndPage 966
ExternalDocumentID 31711068
10_1038_s41390_019_0668_1
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-Q-
.-D
.55
.GJ
08G
0R~
123
2WC
3V.
406
4Q1
4Q2
4Q3
53G
5RE
5VS
70F
77Y
7X7
88E
8C1
8FI
8FJ
AACDK
AAKAS
AANZL
AASML
AATNV
AAWTL
AAYEP
AAYZH
AAZLF
ABAKF
ABAWZ
ABJNI
ABLJU
ABOCM
ABPPZ
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMJI
ACRQY
ACZOJ
ADBBV
ADBIZ
ADFPA
ADHDB
ADZCM
AE3
AE6
AEFQL
AEJRE
AEMSY
AENEX
AEVLU
AEXYK
AFBBN
AFKRA
AFSHS
AFTRI
AFUWQ
AGAYW
AGHAI
AGQEE
AHRYX
AHSBF
AHVBC
AIGIU
AILAN
AIZYK
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AWKKM
AXYYD
BAWUL
BENPR
BKKNO
BPHCQ
BS7
BVXVI
CCPQU
CS3
DIK
DNIVK
DPUIP
DU5
EBLON
EBS
EE.
EIOEI
EJD
EX3
F2K
F2L
F2M
F2N
F5P
FDQFY
FERAY
FIGPU
FIZPM
FRP
FSGXE
FYUFA
H0~
HMCUK
IWAJR
JF9
JG8
JK3
JSO
JZLTJ
K8S
KD2
KMI
L7B
M18
M1P
N9A
NAO
NQJWS
NXXTH
N~M
OAG
OAH
ODA
OK1
OL1
OLG
OLH
OLU
OLV
OLY
OLZ
OVD
OWU
OWV
OWW
OWX
OWY
OWZ
P-K
P2P
PQQKQ
PROAC
PSQYO
R58
RNT
RNTTT
ROL
S4R
SJN
SNX
SNYQT
SOHCF
SOJ
SRMVM
SWTZT
T8P
TAOOD
TBHMF
TDRGL
TEORI
TR2
UKHRP
VVN
W2D
W3M
WOQ
WOW
X7M
XXN
XYM
YFH
YOC
ZFV
ZXP
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
AEZWR
AFDZB
AFHIU
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
NPM
7XB
8FK
ABRTQ
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
7X8
ID FETCH-LOGICAL-c372t-d9d30be218057454d71dea119dbc4eae753c9c521f79becdde01af0ba9e09d953
IEDL.DBID 7X7
ISSN 0031-3998
1530-0447
IngestDate Fri Jul 11 15:16:47 EDT 2025
Fri Jul 25 09:00:12 EDT 2025
Wed Feb 19 02:30:25 EST 2025
Tue Jul 01 01:03:17 EDT 2025
Thu Apr 24 23:08:09 EDT 2025
Fri Feb 21 02:38:07 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c372t-d9d30be218057454d71dea119dbc4eae753c9c521f79becdde01af0ba9e09d953
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-1718-7137
PMID 31711068
PQID 2387246367
PQPubID 105497
PageCount 6
ParticipantIDs proquest_miscellaneous_2314013423
proquest_journals_2387246367
pubmed_primary_31711068
crossref_primary_10_1038_s41390_019_0668_1
crossref_citationtrail_10_1038_s41390_019_0668_1
springer_journals_10_1038_s41390_019_0668_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-04-01
PublicationDateYYYYMMDD 2020-04-01
PublicationDate_xml – month: 04
  year: 2020
  text: 2020-04-01
  day: 01
PublicationDecade 2020
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
PublicationSubtitle Official publication of the American Pediatric Society, the European Society for Paediatric Research and the Society for Pediatric Research
PublicationTitle Pediatric research
PublicationTitleAbbrev Pediatr Res
PublicationTitleAlternate Pediatr Res
PublicationYear 2020
Publisher Nature Publishing Group US
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group US
– name: Nature Publishing Group
References Lin (CR3) 2015; 100
(CR5) 2014; 78
Tremoulet (CR16) 2018; 21
McCrindle (CR2) 2017; 135
Chen, Chang (CR14) 2010; 51
Newburger, Takahashi, Burns (CR6) 2016; 67
Knockaert (CR20) 2007; 28
CR7
Wu, Lin, Chen, Kao, Huang (CR12) 2017; 180
Tremoulet (CR8) 2008; 153
Kobayashi (CR17) 2012; 379
Ogata (CR18) 2012; 129
Hashino (CR9) 2001; 43
Seo (CR10) 2016; 59
Newburger (CR13) 2004; 110
Dominguez (CR19) 2008; 122
Lin, Wu (CR4) 2017; 2017
Lin, Fu, Huang, Huang, Wu (CR15) 2013; 32
Kanegaye (CR11) 2009; 123
Kawasaki (CR1) 1967; 16
JT Kanegaye (668_CR11) 2009; 123
K Hashino (668_CR9) 2001; 43
MH Wu (668_CR12) 2017; 180
SR Dominguez (668_CR19) 2008; 122
S Ogata (668_CR18) 2012; 129
JW Newburger (668_CR13) 2004; 110
JW Newburger (668_CR6) 2016; 67
MT Lin (668_CR4) 2017; 2017
DC Knockaert (668_CR20) 2007; 28
MT Lin (668_CR3) 2015; 100
W Chen (668_CR14) 2010; 51
T Kobayashi (668_CR17) 2012; 379
JCS Joint Working Group. (668_CR5) 2014; 78
AH Tremoulet (668_CR16) 2018; 21
MT Lin (668_CR15) 2013; 32
T Kawasaki (668_CR1) 1967; 16
AH Tremoulet (668_CR8) 2008; 153
668_CR7
E Seo (668_CR10) 2016; 59
BW McCrindle (668_CR2) 2017; 135
References_xml – volume: 2017
  start-page: e201720
  year: 2017
  ident: CR4
  article-title: The global epidemiology of Kawasaki disease: review and future perspectives
  publication-title: Glob. Cardiol. Sci. Pract.
– volume: 180
  start-page: 80.e2
  year: 2017
  end-page: 86.e2
  ident: CR12
  article-title: Postnatal risk of acquiring Kawasaki disease: a nationwide birth cohort database study
  publication-title: J. Pediatr.
  doi: 10.1016/j.jpeds.2016.09.052
– volume: 379
  start-page: 1613
  year: 2012
  end-page: 1620
  ident: CR17
  article-title: RAISE study group investigators. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)61930-2
– volume: 51
  start-page: 69
  year: 2010
  end-page: 79
  ident: CR14
  article-title: New growth charts for Taiwanese children and adolescents based on World Health Organization standards and health-related physical fitness
  publication-title: Pediatr. Neonatol.
  doi: 10.1016/S1875-9572(10)60014-9
– volume: 153
  start-page: 117
  year: 2008
  end-page: 121
  ident: CR8
  article-title: Resistance to intravenous immunoglobulin in children with Kawasaki disease
  publication-title: J. Pediatr.
  doi: 10.1016/j.jpeds.2007.12.021
– volume: 135
  start-page: e927
  year: 2017
  end-page: e929
  ident: CR2
  article-title: Diagnosis, treatment, and long-term management of Kawasaki disease: a Scientific Statement for Health Professionals From the American Heart Association
  publication-title: Circulation
  doi: 10.1161/CIR.0000000000000484
– volume: 78
  start-page: 2521
  year: 2014
  end-page: 2562
  ident: CR5
  article-title: Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version
  publication-title: Circ. J.
  doi: 10.1253/circj.CJ-66-0096
– volume: 67
  start-page: 1738
  year: 2016
  end-page: 1749
  ident: CR6
  article-title: Kawasaki disease
  publication-title: J. Am. Coll. Cardiol.
  doi: 10.1016/j.jacc.2015.12.073
– volume: 59
  start-page: 408
  year: 2016
  end-page: 413
  ident: CR10
  article-title: Prediction of unresponsiveness to second intravenous immunoglobulin treatment in patients with Kawasaki disease refractory to initial treatment
  publication-title: Korean J. Pediatr.
  doi: 10.3345/kjp.2016.59.10.408
– ident: CR7
– volume: 28
  start-page: 1797
  year: 2007
  end-page: 1804
  ident: CR20
  article-title: Cardiac involvement in systemic inflammatory diseases
  publication-title: Eur. Heart J.
  doi: 10.1093/eurheartj/ehm193
– volume: 43
  start-page: 211
  year: 2001
  end-page: 217
  ident: CR9
  article-title: Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy
  publication-title: Pediatr. Int.
  doi: 10.1046/j.1442-200x.2001.01373.x
– volume: 129
  start-page: e17
  year: 2012
  end-page: e23
  ident: CR18
  article-title: Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial
  publication-title: Pediatrics
  doi: 10.1542/peds.2011-0148
– volume: 122
  start-page: e786
  year: 2008
  end-page: e790
  ident: CR19
  article-title: Kawasaki disease in a pediatric intensive care unit: a case-control study
  publication-title: Pediatrics
  doi: 10.1542/peds.2008-1275
– volume: 123
  start-page: e783
  year: 2009
  end-page: e789
  ident: CR11
  article-title: Recognition of a Kawasaki disease shock syndrome
  publication-title: Pediatrics
  doi: 10.1542/peds.2008-1871
– volume: 110
  start-page: 2747
  year: 2004
  end-page: 2771
  ident: CR13
  article-title: Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease; Council on Cardiovascular Disease in the Young; American Heart Association; American Academy of Pediatrics. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000145143.19711.78
– volume: 100
  start-page: 542
  year: 2015
  end-page: 547
  ident: CR3
  article-title: Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous gamma-immunoglobulin therapy
  publication-title: Arch. Dis. Child.
  doi: 10.1136/archdischild-2014-306427
– volume: 32
  start-page: 1384
  year: 2013
  end-page: 1386
  ident: CR15
  article-title: Population-based study of Kawasaki disease shock syndrome in Taiwan
  publication-title: Pediatr. Infect. Dis. J.
  doi: 10.1097/INF.0b013e31829efae6
– volume: 16
  start-page: 178
  year: 1967
  end-page: 222
  ident: CR1
  article-title: Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children
  publication-title: Arerugi
– volume: 21
  start-page: 76
  year: 2018
  end-page: 79
  ident: CR16
  article-title: Adjunctive therapies in Kawasaki disease
  publication-title: Int. J. Rheum. Dis.
  doi: 10.1111/1756-185X.13208
– volume: 16
  start-page: 178
  year: 1967
  ident: 668_CR1
  publication-title: Arerugi
– volume: 135
  start-page: e927
  year: 2017
  ident: 668_CR2
  publication-title: Circulation
  doi: 10.1161/CIR.0000000000000484
– volume: 51
  start-page: 69
  year: 2010
  ident: 668_CR14
  publication-title: Pediatr. Neonatol.
  doi: 10.1016/S1875-9572(10)60014-9
– volume: 2017
  start-page: e201720
  year: 2017
  ident: 668_CR4
  publication-title: Glob. Cardiol. Sci. Pract.
– volume: 123
  start-page: e783
  year: 2009
  ident: 668_CR11
  publication-title: Pediatrics
  doi: 10.1542/peds.2008-1871
– volume: 67
  start-page: 1738
  year: 2016
  ident: 668_CR6
  publication-title: J. Am. Coll. Cardiol.
  doi: 10.1016/j.jacc.2015.12.073
– volume: 110
  start-page: 2747
  year: 2004
  ident: 668_CR13
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000145143.19711.78
– volume: 32
  start-page: 1384
  year: 2013
  ident: 668_CR15
  publication-title: Pediatr. Infect. Dis. J.
  doi: 10.1097/INF.0b013e31829efae6
– volume: 180
  start-page: 80.e2
  year: 2017
  ident: 668_CR12
  publication-title: J. Pediatr.
  doi: 10.1016/j.jpeds.2016.09.052
– volume: 21
  start-page: 76
  year: 2018
  ident: 668_CR16
  publication-title: Int. J. Rheum. Dis.
  doi: 10.1111/1756-185X.13208
– volume: 78
  start-page: 2521
  year: 2014
  ident: 668_CR5
  publication-title: Circ. J.
  doi: 10.1253/circj.CJ-66-0096
– ident: 668_CR7
  doi: 10.1007/978-4-431-56039-5
– volume: 122
  start-page: e786
  year: 2008
  ident: 668_CR19
  publication-title: Pediatrics
  doi: 10.1542/peds.2008-1275
– volume: 59
  start-page: 408
  year: 2016
  ident: 668_CR10
  publication-title: Korean J. Pediatr.
  doi: 10.3345/kjp.2016.59.10.408
– volume: 153
  start-page: 117
  year: 2008
  ident: 668_CR8
  publication-title: J. Pediatr.
  doi: 10.1016/j.jpeds.2007.12.021
– volume: 129
  start-page: e17
  year: 2012
  ident: 668_CR18
  publication-title: Pediatrics
  doi: 10.1542/peds.2011-0148
– volume: 379
  start-page: 1613
  year: 2012
  ident: 668_CR17
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)61930-2
– volume: 100
  start-page: 542
  year: 2015
  ident: 668_CR3
  publication-title: Arch. Dis. Child.
  doi: 10.1136/archdischild-2014-306427
– volume: 43
  start-page: 211
  year: 2001
  ident: 668_CR9
  publication-title: Pediatr. Int.
  doi: 10.1046/j.1442-200x.2001.01373.x
– volume: 28
  start-page: 1797
  year: 2007
  ident: 668_CR20
  publication-title: Eur. Heart J.
  doi: 10.1093/eurheartj/ehm193
SSID ssj0014584
Score 2.3784623
Snippet Background We aimed to investigate the clinical implications of unresponsiveness to single or repeated courses intravenous immunoglobulin (IVIG) and Kawasaki...
We aimed to investigate the clinical implications of unresponsiveness to single or repeated courses intravenous immunoglobulin (IVIG) and Kawasaki disease (KD)...
BackgroundWe aimed to investigate the clinical implications of unresponsiveness to single or repeated courses intravenous immunoglobulin (IVIG) and Kawasaki...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 961
SubjectTerms Aneurysms
Immunoglobulins
Kawasaki disease
Medicine
Medicine & Public Health
Pediatric Surgery
Pediatrics
Population Study Article
Title Shock and unresponsiveness to repeated courses of intravenous immunoglobulin in Kawasaki disease: a nationwide database study
URI https://link.springer.com/article/10.1038/s41390-019-0668-1
https://www.ncbi.nlm.nih.gov/pubmed/31711068
https://www.proquest.com/docview/2387246367
https://www.proquest.com/docview/2314013423
Volume 87
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NTxsxEB0VIlVcEC2FLqTISJyoVng_EttcEEVBUVFQVYqU28prOyIS2k1JgBP_nRmvN6iKymUv-yk_78wbz_gNwFGGmGK0w2NuhG9hNomV5SIWpRRa5tpIQRuFR9f94W3-c9wbhwW3eSirbG2iN9S2NrRGfoKuRaSkbiXOZn9j6hpF2dXQQmMNOiRdRiVdYrwMuBLKATayjEmMjli2Wc1MnszReCsqyfJ78DGQ-tcvrZDNlUSp9z-XW7AZiCM7b5D-BB9c9Rk-jkJqfBtebu7QtDFdWfZIEj6-8rWxZGxRswc3Q6vrLDO1L9tg9YRNaWH3yYu0sintE6lJHoRK0_EUu9LPeo78koUczinTrFk6fJ5ax6i0lFwg8wK1X-D2cvDnYhiH3gqxyUS6iK2yGS8dOngkbHkvtyKxTuMg2tLkTjuMYowy6NsnQiHMaAR5oie81MpxZVUv24H1qq7cV2BOJpnguZbUsqNMMo0kJ9e6tKnqG532IuDtyBYmCI9T_4v7wifAM1k0YBQIRkFgFEkEx8tbZo3qxnsXd1u4ivADzou36RLB4fI0_jqUD9GVw5HFa3x0iYQygt0G5uXbkFYhMerLCL63uL89_L-fsvf-p-zDRkrhui_86cL64uHRfUNOsygP_MTFo7xIDqDzY3D96_crqz71Cw
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB5VqQRcUHlvH9RIcAGt6n0ktpEqBKVVSpoIQSv1Zry2IyJVu2mTNuLAX-I3MuPdTYUqeuvZ3l2vx575xt94BuB1hjJFb4fH3IpQwmwcK8dFLAopjMyNlYIuCg9Hvf5J_uW0e7oCf9q7MBRW2erEoKhdZemMfAdNi0gpu5X4MD2PqWoUsattCY16WQz8rwW6bLPdw88o3zdperB_vNePm6oCsc1EOo-dchkvPJo2hCp5N3cicd4kiXKFzb3xiN-tsmjVxkLhD-L254kZ88Ioz5VTVCUCVf5qnqEr04HVT_ujr9-WvAWxjnUiyCRG0y9bHjWTOzM0F4qCwMKtf3Td_rWEN-DtDWo2WLyDNXjYQFX2sV5bj2DFl4_h3rAh45_A7-8_UZkyUzp2SUmDQqxtrTvZvGIXfop63jtmqxAowqoxm9BR8lVIC8smdDOlooQkFAyPTWxgFmaGiJY1rNF7Zlh9WLmYOM8omJWMLgspcZ_CyZ3M-zPolFXpXwDzMskEz42kIiFFkhmEVbkxhUtVz5q0GwFvZ1bbJtU5Vdw404Fyz6SuhaFRGJqEoZMI3i4fmdZ5Pm7rvNmKSzdbfqavF2gEr5bNuFmJgTGlx5nFPsGfRQgbwfNazMuvIZBDKNaTEbxr5X798v8OZf32oWzD_f7x8EgfHY4GG_AgpcOCEHa0CZ35xaXfQkQ1L142y5jBj7veOX8BIXQyjA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3daxQxEB9KheKL-O1q1Qj6oiyX7O5dEqEUsR6tZ4ughXuL2SRLD2T37F09fPAf61_XmezuFSn2rc_J7mYzmZnffGQG4HWONEVrh6fcydjCrEq15zKVpZJWFdYpSReFD49G-8fF5-lwugHn_V0YSqvsZWIU1L5x5CMfoGqRGVW3koOqS4v4ujfenf9KqYMURVr7dhrtEZmEPys03xY7B3tI6zdZNv70_eN-2nUYSF0us2Xqtc95GVDNIWwphoWXwgcrhPalK4INiOWddqjhKqnxZ1EUcGErXloduPaaOkag-L8l86EgHpPTtbEnKP7YloQUKYIA1UdUczVYoOLQlA4W7_-jEfevTrwCdK8EaaPuG9-FOx1oZR_aU3YPNkJ9H7YOu7D8A_j77QTFKrO1Z2dUPihm3bZSlC0bdhrmKPGDZ66JKSOsqdiMnMq_Y4FYNqM7Kg2VJqG0eBxiE7uyC8S2rIsfvWeWtW7L1cwHRmmtpH5ZLI77EI5vZNcfwWbd1OEJsKBELnlhFbULKUVuEWAV1pY-0yNns2ECvN9Z47qi59R746eJwfdcmZYYBolhiBhGJPB2_ci8rfhx3eTtnlymY_6FuTyqCbxaDyPbUizG1gF3FudEyxbBbAKPWzKvv4aQDkHZSCXwrqf75cv_u5Sn1y_lJWwhv5gvB0eTZ3A7I69BzD_ahs3l6Vl4jtBqWb6IZ5jBj5tmmgsQxjVc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Shock+and+unresponsiveness+to+repeated+courses+of+intravenous+immunoglobulin+in+Kawasaki+disease%3A+a+nationwide+database+study&rft.jtitle=Pediatric+research&rft.au=Yun-Chieh%2C+Liang&rft.au=Chin-Hao%2C+Chang&rft.au=Ming-Tai%2C+Lin&rft.au=Feng-Yu%2C+Kao&rft.date=2020-04-01&rft.pub=Nature+Publishing+Group&rft.issn=0031-3998&rft.eissn=1530-0447&rft.volume=87&rft.issue=5&rft.spage=961&rft.epage=966&rft_id=info:doi/10.1038%2Fs41390-019-0668-1&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0031-3998&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0031-3998&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0031-3998&client=summon